mcK6A1 is an inhibitor for the aggregation of amyloid-beta (Abeta), that selectively binds to the 16KLVFFA21 segment of Abeta42, forms an extended beta-folded structure, and inhibits the formation of Abeta42 oligomers. mcK6A1 can be used in research of Alzheimers disease and other amyloid-related diseases[1].
Molecular Weight:
1446.65
Formula:
C71H99N17O16
Target:
Amyloid-beta
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
